Daily aspirin may prevent distant cancer metastasis, according to a recent analysis. Researchers from the United Kingdom examined 5 large, randomized trials (17,285 participants) of daily aspirin (≥75 mg daily) vs control for the prevention of vascular events to assess the effect of aspirin on the frequency of distant metastasis…
Read more »
Long-term aspirin use may offer protection against cancer, a recent study has found. In analyzing data from 6 trials of daily low-dose aspirin in the primary prevention of vascular events (35,535 participants) and 51 clinical trials (including 34 randomized trials) of daily aspirin vs controls for the prevention of vascular…
Read more »
indicates a Peer-Reviewed Article
Risk of bleeding with daily aspirin may offset benefit in low-risk patients
Chronic use of low-dose aspirin, defined as 300 mg/day or less, is associated with an increased risk of major gastrointestinal (GI) or cerebral bleeding, a recent review of administrative data found. Patients with diabetes also were found to have a high rate of bleeding, irrespective of aspirin use. Key Point:…
Read more »